Liselotte Nilsson

Sales & Marketing at CLINICAL LASERTHERMIA SYSTEMS AB

54 year

Health Technology

Commercial Services

Profile

Liselotte Nilsson is currently the Vice President-Marketing at Clinical Laserthermia Systems AB since 2021.
Prior to this, she worked as the Head-Marketing at Phase Holographic Imaging AB, Marketing Manager at ProstaLund AB, and Marketing Manager at Svar Life Science AB.

Liselotte Nilsson active positions

Companies	Position	Start
CLINICAL LASERTHERMIA SYSTEMS AB	Sales & Marketing	01/01/2021

All active positions of Liselotte Nilsson

Former positions of Liselotte Nilsson

Companies	Position	End
PROSTALUND AB	Sales & Marketing	-
Svar Life Science AB Svar Life Science AB Miscellaneous Commercial ServicesCommercial Services Svar Life Science AB is a Swedish company that provides GMP and non-GMP bioassay services for drug development. The private company is based in Malmö, Sweden. The company specializes in using activity biomarkers to determine if deficiencies, overactivation, or dysregulation in the complement system are causing or contributing to a person's disease or condition. The company offers method development, qualification, validation, and method improvements throughout the drug development lifecycle. Anne Thjømøe has been the CEO of the company since 2022.	Sales & Marketing	-
PHASE HOLOGRAPHIC IMAGING PHI AB	Sales & Marketing	-

See the detail of Liselotte Nilsson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Liselotte Nilsson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
CLINICAL LASERTHERMIA SYSTEMS AB	Health Technology
PHASE HOLOGRAPHIC IMAGING PHI AB	Health Technology
PROSTALUND AB	Health Technology

Private companies	1
Svar Life Science AB Svar Life Science AB Miscellaneous Commercial ServicesCommercial Services Svar Life Science AB is a Swedish company that provides GMP and non-GMP bioassay services for drug development. The private company is based in Malmö, Sweden. The company specializes in using activity biomarkers to determine if deficiencies, overactivation, or dysregulation in the complement system are causing or contributing to a person's disease or condition. The company offers method development, qualification, validation, and method improvements throughout the drug development lifecycle. Anne Thjømøe has been the CEO of the company since 2022.	Commercial Services